Page History
The Adverse Events (AE) domain is based on the Events General Observation class. The AE domain is used to represent clinical data describing "any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment" (ICH E2A: https://www.fda.gov/regulatory-information). In consultation with regulatory authorities, applicants may extend or limit the scope of adverse event collection (e.g., collecting pre-treatment events related to trial conduct, not collecting events that are assessed as efficacy endpoints). Events included in the AE domain should be consistent with protocol requirements. Adverse event terms may be captured either as free text or via a prespecified list of terms.
...
| Example | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
This is an example of a CRF used to collect all adverse events that occurred after informed consent is obtained. Adverse events were collected using free-text. This CRF was designed to allow the applicant to use either AEENRF or AEENRTPT to represent an event that was ongoing.
This SDTM dataset illustrates data collected on the example AE CRF above. This SDTM dataset used AENRTPT. More information can be found in Section 2.8.7.6, Representing References and Relative Timing.
|
...
Overview
Content Tools